Related Experiment Videos
Mezlocillin treatment of septicemia in general hospitals
Abstract:
Gramnegative septicemia in 23 patients from different Norwegian departments of general medicine or surgery was treated with mezlocillin. Most of the patients were old, and 14 patients were considered compromised due to underlying disease. In the majority of cases the septicemia originated from urinary tract infections. Uneventful recovery was accomplished in 16 patients (70%) and another 5 cases improved. In 2 patients no clinical effects were observed within 3 days of treatment. Apart from diarrhoea in 5 of the cases, no side-effects occurred. Mezlocillin proved to be a safe and efficient drug for the treatment of gramnegative septicemias of the type that is most commonly encountered in Norwegian general hospitals.
Insights
Mezlocillin effectively treated gramnegative septicemia in elderly and compromised patients, with most cases originating from urinary tract infections. The antibiotic demonstrated safety and efficacy in a Norwegian hospital setting.
Area of Science:
- Infectious Diseases
- Pharmacology
- Internal Medicine
Background:
- Gram-negative septicemia is a serious condition often affecting elderly and immunocompromised individuals.
- Urinary tract infections are a common source of gram-negative septicemia in hospital settings.
- Mezlocillin is an antibiotic used for treating bacterial infections.
Purpose of the Study:
- To evaluate the efficacy and safety of mezlocillin in treating gram-negative septicemia.
- To assess treatment outcomes in a patient population with common comorbidities.
- To determine the incidence of side effects associated with mezlocillin therapy.
Main Methods:
- A study involving 23 patients with gram-negative septicemia treated with mezlocillin.
- Patients were drawn from general medicine and surgery departments in Norwegian hospitals.
- Data collection focused on treatment outcomes, patient demographics, and adverse events.
Main Results:
- 16 patients (70%) achieved uneventful recovery, and 5 (22%) improved.
- Gram-negative septicemia primarily originated from urinary tract infections.
- Diarrhea was the most common side effect, occurring in 5 patients; no other significant adverse events were reported.
Conclusions:
- Mezlocillin is a safe and effective treatment for gram-negative septicemia commonly seen in Norwegian general hospitals.
- The drug shows significant efficacy in elderly patients and those with underlying health conditions.
- Mezlocillin is a viable therapeutic option for gram-negative bloodstream infections, particularly those stemming from UTIs.